Literature DB >> 27151926

Klotho May Ameliorate Proteinuria by Targeting TRPC6 Channels in Podocytes.

Ji-Hee Kim1, Jian Xie2, Kyu-Hee Hwang1, Yueh-Lin Wu2,3, Noelynn Oliver4, Minseob Eom5, Kyu-Sang Park1,6, Nestor Barrezueta4, In-Deok Kong1,6, R Paul Fracasso4, Chou-Long Huang7, Seung-Kuy Cha8,6.   

Abstract

Klotho is a type-1 membrane protein predominantly produced in the kidney, the extracellular domain of which is secreted into the systemic circulation. Membranous and secreted Klotho protect organs, including the kidney, but whether and how Klotho directly protects the glomerular filter is unknown. Here, we report that secreted Klotho suppressed transient receptor potential channel 6 (TRPC6)-mediated Ca2+ influx in cultured mouse podocytes by inhibiting phosphoinositide 3-kinase-dependent exocytosis of the channel. Furthermore, soluble Klotho reduced ATP-stimulated actin cytoskeletal remodeling and transepithelial albumin leakage in these cells. Overexpression of TRPC6 by gene delivery in mice induced albuminuria, and exogenous administration of Klotho ameliorated the albuminuria. Notably, immunofluorescence and in situ hybridization revealed Klotho expression in podocytes of mouse and human kidney. Heterozygous Klotho-deficient CKD mice had aggravated albuminuria compared with that in wild-type CKD mice with a similar degree of hypertension and reduced clearance function. Finally, disrupting the integrity of glomerular filter by saline infusion-mediated extracellular fluid volume expansion increased urinary Klotho excretion. These results reveal a potential novel function of Klotho in protecting the glomerular filter, and may offer a new therapeutic strategy for treatment of proteinuria.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Klotho; TRPC6; podocyte

Mesh:

Substances:

Year:  2016        PMID: 27151926      PMCID: PMC5198269          DOI: 10.1681/ASN.2015080888

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  50 in total

1.  Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys.

Authors:  Y Kato; E Arakawa; S Kinoshita; A Shirai; A Furuya; K Yamano; K Nakamura; A Iida; H Anazawa; N Koh; A Iwano; A Imura; T Fujimori; M Kuro-o; N Hanai; K Takeshige; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  2000-01-19       Impact factor: 3.575

2.  Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma.

Authors:  Ji-Hee Kim; Sayamaa Lkhagvadorj; Mi-Ra Lee; Kyu-Hee Hwang; Hyun Chul Chung; Jae Hung Jung; Seung-Kuy Cha; Minseob Eom
Journal:  Biochem Biophys Res Commun       Date:  2014-04-19       Impact factor: 3.575

3.  Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling.

Authors:  Lili Zhou; Yingjian Li; Dong Zhou; Roderick J Tan; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 10.121

4.  WNK1 promotes PIP₂ synthesis to coordinate growth factor and GPCR-Gq signaling.

Authors:  Sung-Wan An; Seung-Kuy Cha; Joonho Yoon; Seungwoo Chang; Elliott M Ross; Chou-Long Huang
Journal:  Curr Biol       Date:  2011-11-23       Impact factor: 10.834

5.  Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.

Authors:  Daniela Macconi; Mauro Abbate; Marina Morigi; Stefania Angioletti; Marilena Mister; Simona Buelli; Maria Bonomelli; Peter Mundel; Karlhans Endlich; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  Intravital imaging of podocyte calcium in glomerular injury and disease.

Authors:  James L Burford; Karie Villanueva; Lisa Lam; Anne Riquier-Brison; Matthias J Hackl; Jeffrey Pippin; Stuart J Shankland; János Peti-Peterdi
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

7.  TRPC6 enhances angiotensin II-induced albuminuria.

Authors:  Jason Eckel; Peter J Lavin; Elizabeth A Finch; Nirvan Mukerji; Jarrett Burch; Rasheed Gbadegesin; Guanghong Wu; Brandy Bowling; Alison Byrd; Gentzon Hall; Matthew Sparks; Zhu Shan Zhang; Alison Homstad; Laura Barisoni; Lutz Birbaumer; Paul Rosenberg; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2011-01-21       Impact factor: 10.121

8.  Lanthanides potentiate TRPC5 currents by an action at extracellular sites close to the pore mouth.

Authors:  Silke Jung; Anja Mühle; Michael Schaefer; Rainer Strotmann; Gunter Schultz; Tim D Plant
Journal:  J Biol Chem       Date:  2002-11-26       Impact factor: 5.157

Review 9.  The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2009-11       Impact factor: 43.330

10.  Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species.

Authors:  Marc Anderson; Hila Roshanravan; Justin Khine; Stuart E Dryer
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

View more
  32 in total

1.  Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling.

Authors:  George Dalton; Sung-Wan An; Saif I Al-Juboori; Nicole Nischan; Joonho Yoon; Evgenia Dobrinskikh; Donald W Hilgemann; Jian Xie; Kate Luby-Phelps; Jennifer J Kohler; Lutz Birnbaumer; Chou-Long Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

2.  Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.

Authors:  Yueh-Lin Wu; Jian Xie; Sung-Wan An; Noelynn Oliver; Nestor X Barrezueta; Mei-Hsiang Lin; Lutz Birnbaumer; Chou-Long Huang
Journal:  Kidney Int       Date:  2016-12-12       Impact factor: 10.612

3.  Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease.

Authors:  Rik Mencke; Geert Harms; Jill Moser; Matijs van Meurs; Arjan Diepstra; Henri G Leuvenink; Jan-Luuk Hillebrands
Journal:  JCI Insight       Date:  2017-10-19

4.  Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.

Authors:  Ming Chang Hu; Mingjun Shi; Nancy Gillings; Brianna Flores; Masaya Takahashi; Makoto Kuro-O; Orson W Moe
Journal:  Kidney Int       Date:  2017-01-25       Impact factor: 10.612

5.  P2X7 receptor and klotho expressions in diabetic nephropathy progression.

Authors:  A M Rodrigues; R S Serralha; C Farias; G R Punaro; M J S Fernandes; Elisa Mieko Suemitsu Higa
Journal:  Purinergic Signal       Date:  2018-03-14       Impact factor: 3.765

Review 6.  The Klotho proteins in health and disease.

Authors:  Makoto Kuro-O
Journal:  Nat Rev Nephrol       Date:  2019-01       Impact factor: 28.314

7.  Klotho suppresses the renin-angiotensin system in adriamycin nephropathy.

Authors:  Tsuneo Takenaka; Tsutomu Inoue; Takashi Miyazaki; Hiroyuki Kobori; Akira Nishiyama; Naohito Ishii; Matsuhiko Hayashi; Hiromichi Suzuki
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

Review 8.  Exploiting the neuroprotective effects of α-klotho to tackle ageing- and neurodegeneration-related cognitive dysfunction.

Authors:  Kelsey Hanson; Kate Fisher; Nigel M Hooper
Journal:  Neuronal Signal       Date:  2021-06-14

Review 9.  The Use of Genomics to Drive Kidney Disease Drug Discovery and Development.

Authors:  Dermot F Reilly; Matthew D Breyer
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-19       Impact factor: 8.237

10.  P2X7 siRNA targeted to the kidneys increases klotho and delays the progression of experimental diabetic nephropathy.

Authors:  A M Rodrigues; R S Serralha; D Y Lima; G R Punaro; I Visona; M J S Fernandes; E M S Higa
Journal:  Purinergic Signal       Date:  2020-05-06       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.